Low dose melphalan in the treatment of myelofibrosis: A single centre experience [7]

Leukemia and Lymphoma

Volumn 47, Issue 7, 2006, Pages 1409-1412

  Chee, L ^a   Kalnins, R ^a   Turner, P ^a  

^a AUSTIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANAGRELIDE; ANTINEOPLASTIC AGENT; CYCLOSPORIN A; DEFEROXAMINE; HEMOGLOBIN; HYDROXYUREA; MELPHALAN; PREDNISOLONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; BLOOD ANALYSIS; BLOOD CELL COUNT; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CLINICAL ARTICLE; DEATH; DISEASE COURSE; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; EXPERIENCE; FEMALE; HUMAN; LETTER; LOW DRUG DOSE; LUNG EDEMA; MALE; MYELOFIBROSIS; MYELOID METAPLASIA; NEUTROPENIA; PERICARDIAL EFFUSION; POLYCYTHEMIA; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; RELAPSE; SEPSIS; SPLENECTOMY; SPLENOMEGALY; STAPHYLOCOCCUS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; FEMALE; HUMANS; MALE; MELPHALAN; MIDDLE AGED; MYELOFIBROSIS; MYELOID METAPLASIA; PHENOTYPE; PRIMARY MYELOFIBROSIS; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33747652900     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600604088     Document Type: Letter

References (6)

1. Manoharan, A and Pitney, W. (1984) Chemotherapy resolves symptoms and reverses marrow fibrosis in myelofibrosis. Scand J Haematol, 33, pp. 453-459.
2. Lofvenberg, E and Wahlin, A and Roos, G and Ost, A. (1990) Reversal of myelofibrosis by hydroxyurea. Eur J Haematol, 44, pp. 33-38.
3. Stott, H and Fox, W and Girling, D and Stephens, R and Galton, D. (1977) Acute leukemia after busulphan. BMJ, 2, pp. 1513-1517.
4. Rupoli, S and Da Lio, L and Sisti, S and Campanati, G and Salvi, A and Brianzoni, M and (1994) Primary myelofibrosis: A detailed statistical analysis of the clinicopathological variables influencing survival. Ann Haematol, 68, pp. 205-212.
5. Petti, M and Latagliata, R and Spadea, T and Spadea, A and Montefusco, E and Aloe Spiriti, M and (2002) Melphalan treatment in patients with myelofibrosis with myeloid metaplasia. Br J Haematol, 116, pp. 576-581.
6. Dray, S and Mokyr, M. (1989) Cyclophosphamide and melphalan as immunopotentiating agents in cancer therapy. Med Oncol Tumor Pharmacother, 6, pp. 77-85.